We are Prime

We are Prime Prime We provide the world’s leading biotech, pharma and healthcare businesses with professional communications and strategic consultancy services.

Prime Global
The Medical Communications People

Prime Global is a group of seven full-service medical communications agencies and four specialist consultancies. Through our offices across the UK and US, our exceptionally highly qualified scientific teams deliver expertise across a wide range of therapy areas, with a passionate belief in the value of creative, innovative science communication. People are at the heart of everything we do. From the colleagues we work with to the clients we support every day, and ultimately to patients everywhere whose lives we help to make better. www.primeglobalpeople.com

🌍 As draws to a close, we’re proud to reflect on how we’re turning our sustainability commitments into action. From ev...
21/11/2025

🌍 As draws to a close, we’re proud to reflect on how we’re turning our sustainability commitments into action.

From evolving our comprehensive Environmental, Social, and Governance (ESG) strategy to embedding energy-saving initiatives through the UK Government’s Energy Savings Opportunity Scheme (ESOS), we’re driving change that makes a measurable difference. 🌱

We’re also offsetting our carbon footprint through global and local partnerships, supporting Forest Carbon’s woodland and peatland restoration in the UK, treebytree’s reforestation projects in Africa, and by partnering with Ecologi to plant trees for every 10 colleagues who took part in our Summer Step Up Challenge, where we collectively clocked steps across a virtual route from Venice, Italy to Szczecin, Poland. 🌳

It’s all part of our journey toward a healthier planet; where sustainability, science, and strategy work hand in hand.

We’re thrilled to have won the Patient-Centricity Award at the 2025 PMEA Awards! 🏆 This award recognises our partnershi...
20/11/2025

We’re thrilled to have won the Patient-Centricity Award at the 2025 PMEA Awards! 🏆

This award recognises our partnership with Great Ormond Street Hospital and Charity to create Rheumbot – an interactive chatbot helping the families of young people with chronic rheumatological conditions feel informed, supported and connected.

A huge thank you to PMEA for celebrating work that brings science and creativity together to make a real impact for patients, and congratulations to all this year’s winners and finalists! 💙

✨ Thank you to ISMPP International Society for Medical Publication Professionals for an engaging and insightful meeting ...
19/11/2025

✨ Thank you to ISMPP International Society for Medical Publication Professionals for an engaging and insightful meeting in Boston last week.

And a huge thank you to everyone who joined Valerie Moss, Jennifer Ghith, and Monica Mody for great discussion and debate during .

On Thursday, the “Lean Teams, Smart Working: AI Implementation for Small Companies and/or Small Teams with Big Ideas” session explored how smaller teams can harness generative AI to boost efficiency and quality. As part of this session, there was a lively “shark tank” challenge, with the teams pitching some great ideas for scaling AI within their organizations.

The momentum continued into Friday’s plenary, “Will AI Replace the Scientific Communications Professional or Make You Irreplaceable?” The verdict: AI isn’t replacing talent, it’s redefining what value means in scientific communications. The panel delved into evolving skillsets, responsible AI use, and how to thrive as an “AI-augmented” communicator.

Attendees left inspired by the energy, ideas, and collaboration on display – it’s clear the community is ready to shape the future of our field! 🌟

It’s nearly time! ✨ Tomorrow night, the Awards celebrate excellence, innovation, and impact across the healthcare and ...
18/11/2025

It’s nearly time! ✨

Tomorrow night, the Awards celebrate excellence, innovation, and impact across the healthcare and life sciences industry, and we’re honoured to be finalists for not one, but two categories:

🎉 Award for Patient-Centricity
🎉 Excellence in Innovation

We’ve been shortlisted for our work supporting young people with chronic rheumatological conditions and their families, and for creating ‘Rheumbot’ - a life-changing interactive app with Great Ormond Street Hospital and Charity offering advice from HCPs, hints and tips from parents, and guided coaching conversations.

With an average user score of 4.3 out of 5 and an NPS of 70, the results speak for themselves.

But the real impact is best captured in the words of the patients and their families: “It made me feel safe, more confident, less lonely, less of a burden to the nurse, and [it] had infinite patience”. “[It] empowers you, as a parent, to ask the tricky questions.”

Find out more about the project here: https://loom.ly/5gfNEoE

Fingers crossed for tomorrow evening! 🙌

According to a 2024 report from the World Health Organization (WHO), antimicrobial resistance (AMR) is the third leading...
17/11/2025

According to a 2024 report from the World Health Organization (WHO), antimicrobial resistance (AMR) is the third leading cause of mortality worldwide, 🦠

projecting that AMR will cause 39 million deaths globally over the next 25 years. That is, more than three deaths every minute.

Tomorrow marks the start of World Antimicrobial Awareness Week (18–24 November). This year’s theme, “Act Now: Protect Our Present, Secure Our Future”, calls for urgent, collective action across science, healthcare, and society.

We need innovation to develop new treatments, collaboration through the One Health approach, and stewardship to use existing medicines responsibly.

Protecting the medicines that protect us is everyone’s responsibility.

Don’t miss Wednesday’s ISMPP International Society for Medical Publication Professionals webinar featuring our very own ...
17/11/2025

Don’t miss Wednesday’s ISMPP International Society for Medical Publication Professionals webinar featuring our very own Mel Purves!

Mel will join panelists Sian Kneller, Director, Global Content Design & Delivery, Oncology at GSK, Melissa Goodman, Director, Annual Meeting Programs, Convention & Meetings at American Urological Association and Kindiya Geghman, Vice President, Medical & Scientific Services at Ashfield MedComms, to explore the various types of scientific congresses and their affiliations.

What to expect:
📄 An overview of congresses and their role within the publications ecosystem
✍️ Key components of congress publication activities
🌎 Real-world insights from experts across pharma, agency, and congress organizations

Register here: https://loom.ly/_JyOnIs

Two congresses, one mission: creating optimal portfolio value 🚀 From MedAffairs Transformation to ISPOR, Medical Affairs...
14/11/2025

Two congresses, one mission: creating optimal portfolio value 🚀

From MedAffairs Transformation to ISPOR, Medical Affairs and HEOR/Market Access teams can work collaboratively, guided by the VISTA framework, to climb the optimal path of value creation and patient impact.

Following the recent conference, we caught up with Rebecca Massey, Idaira Rodríguez & the team to hear their key takeaways:

💙 Patient centricity was at the heart of discussions
Sessions focused on integrating patient perspectives across value assessment, pricing, reimbursement, and market access, accelerating truly patient-centered decision making.

🏥 Joint clinical assessments (JCAs) present challenges and uncertainties
Pre-empting market access and JCA challenges earlier in R&D, as well as optimising cross-functional working, will be pivotal for successful outcomes and improved patient access.

🤖 AI can enhance efficiency, but ethical considerations remain
The consensus was clear: technology can support the process, but the human element remains essential.

Many thanks again to all who attended Sue’s VISTA session at MedAffairs Transformation and visited our stand at ISPOR, and thank you for having us, Evidence Life Sciences and ISPOR—The Professional Society for Health Economics and Outcomes Research!

We’re delighted to announce that Megan Pollack has joined our leadership team as Vice President at Prime Aventine – our ...
13/11/2025

We’re delighted to announce that Megan Pollack has joined our leadership team as Vice President at Prime Aventine – our US market access team.

Based in the US, Megan brings extensive experience in payer access and value communications. She previously led US medical and value communications for 9 years, delivering AMCP dossiers, pre-approval information exchange, and CMS Inflation Reduction Act response documents.

Megan also has direct experience in clinical pharmacy and laboratory bench research which gives her unique insight into the full drug development process, from product development to post-approval market access and clinical use.

This appointment marks a significant step in Prime’s continued growth and commitment to expanding our market access services in the US, and Megan's understanding of the landscape will be invaluable to us.

Welcome to Prime’s leadership team, Megan! 👏

Learn more: https://loom.ly/YTel5ZQ

12/11/2025

Heading to the ISMPP International Society for Medical Publication Professionals Academy in Boston tomorrow? Valerie Moss will see you there!

Val will be co-hosting two sessions alongside Jennifer Ghith, Senior Director, Channel Integration and Analytics Lead, Global Scientific Communications at GSK, and Monica Mody, Vice President, Scientific Communications at Madrigal Pharmaceuticals.

Together, they’ll explore two of the most talked-about topics in the community:

🧩 Lean Teams, Smart Working: AI Implementation for Small Companies and/or Small Teams with Big Ideas
🤖 Will AI Replace the Scientific Communications Professional or Make You Irreplaceable? New Skillsets in the AI Age

Expect fresh perspectives, practical insights, and an honest look at how AI is transforming the future of medical and scientific communications.

This year’s ESMO - European Society for Medical Oncology Congress was brimming with optimism for the future of oncology,...
10/11/2025

This year’s ESMO - European Society for Medical Oncology Congress was brimming with optimism for the future of oncology, and we’re still feeling inspired!

Reflecting on her time at the meeting, Valerie Moss shares her top three takeaways:

1️⃣ Precision oncology is accelerating
Circulating tumor DNA (ctDNA) was a prominent theme at , evolving from a research tool to a driver of personalized cancer care. The pivotal IMvigor011 trial showcased how ctDNA can guide earlier intervention in muscle-invasive bladder cancer before recurrence appears on imaging, with the potential to save patients at lower risk from unnecessary treatment.

2️⃣ ADCs and combination strategies are rewriting the playbook
Antibody-drug conjugates (ADCs) took center stage across many tumor types. One HER2-targeted ADC combined with a PD-1 inhibitor nearly doubled overall survival versus standard of care chemotherapy in unresectable locally advanced/metastatic urothelial cancer, earning spontaneous applause from the audience at a packed presidential session and signaling powerful new treatment possibilities.

3️⃣ From breakthroughs to real change
Presidential sessions delivered other practice-changing data across HER2+ breast, muscle-invasive bladder, and platinum-resistant ovarian cancers. The message was clear: earlier treatment, smarter targeting, and better biomarkers are converging to transform patient outcomes.

The future of oncology is taking shape, and collaboration will be key to accelerating it. We’re ready to play our part.

Swipe to learn more 👉

On World Diabetes Day, we’re championing better workplace support for people living with diabetes. Did you know? 📊 7 in...
10/11/2025

On World Diabetes Day, we’re championing better workplace support for people living with diabetes.

Did you know?

📊 7 in 10 people with diabetes are of working age
📊 3 in 4 have experienced anxiety, depression, or another mental health condition because of their diabetes
📊 4 in 5 have experienced diabetes burnout, emotional fatigue and a sense of being overwhelmed

This year’s theme, “Diabetes and the Workplace,” reminds us that small changes in awareness, policy, and understanding can make a real difference to daily wellbeing and long-term health.

Let’s work together to create supportive, inclusive workplaces. 💙

Share your experiences, tips, or ideas for making workplaces diabetes-friendly in the comments and let’s learn from each other.

Did you miss Sue O’Leary’s session at the MedAffairs Transformation conference? In her talk, Sue shared how the VISTA (V...
07/11/2025

Did you miss Sue O’Leary’s session at the MedAffairs Transformation conference?

In her talk, Sue shared how the VISTA (Value and Impact Strategic Trends Assessment) framework enables teams to embed value thinking across functions and deliver better outcomes for patients, payers, and pharma alike.

Our latest whitepaper, “Why Value Demonstration Is Everyone’s Business”, explores this further through the idea of the “value red thread” – a mindset that connects R&D, Medical, HEOR, Market Access and Commercial from asset selection to post launch.

It invites teams to consider:
💡 Are we defining value early enough?
💡 Are our trial endpoints meaningful to both patients and payers?
💡 Are our data and communications aligned to sustain access post launch?

Because demonstrating value isn’t the responsibility of one function alone: it’s everyone’s business.

Download the whitepaper here: https://loom.ly/w_tvouI

Address

Knutsford

Telephone

+441565752100

Website

Alerts

Be the first to know and let us send you an email when We are Prime posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Featured

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category